CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effect...
Enregistré dans:
Auteurs principaux: | Shazia Jamal, Vino T Cheriyan, Magesh Muthu, Sara Munie, Edi Levi, Abdelkader E Ashour, Harvey I Pass, Anil Wali, Mandip Singh, Arun K Rishi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cytomegalovirus infection in malignant pleural mesothelioma.
par: DeVon Hunter-Schlichting, et autres
Publié: (2021) -
Modern management of malignant pleural mesothelioma
par: Patel SC, et autres
Publié: (2016) -
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
par: Anca Nastase, et autres
Publié: (2021) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
par: Sara Ricciardi, et autres
Publié: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
par: Bonomi M, et autres
Publié: (2017)